Metropolitan Life Insurance CO Intra Cellular Therapies, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

50 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$64.37 - $75.65 $30,382 - $35,706	-472 Reduced 8.75%	4,921 $340,000
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $14,428 - $17,755	277 Added 5.41%	5,393 $280,000
Q2 2023 Aug 10, 2023	BUY	$54.67 - $66.44 $9,567 - $11,627	175 Added 3.54%	5,116 $323,000
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $35,215 - $45,819	-804 Reduced 13.99%	4,941 $267,000
Q4 2022 Jun 14, 2023	BUY	$44.07 - $54.45 $35,432 - $43,777	804 Added 16.27%	5,745 $304 Million
Q4 2022 Mar 30, 2023	BUY	$44.07 - $54.45 $9,827 - $12,142	223 Added 4.04%	5,745 $304,000
Q4 2022 Feb 15, 2023	BUY	$44.07 - $54.45 $9,827 - $12,142	223 Added 4.04%	5,745 $304,000
Q3 2022 Jun 14, 2023	BUY	$42.7 - $59.99 $24,808 - $34,854	581 Added 11.76%	5,522 $257 Million
Q2 2022 Jun 20, 2023	BUY	$43.0 - $65.64 $24,983 - $38,136	581 Added 11.76%	5,522 $315,000
Q2 2022 Mar 30, 2023	BUY	$43.0 - $65.64 $16,684 - $25,468	388 Added 7.56%	5,522 $315,000
Q2 2022 Aug 11, 2022	BUY	$43.0 - $65.64 $16,684 - $25,468	388 Added 7.56%	5,522 $315,000
Q1 2022 Jun 20, 2023	BUY	$38.74 - $62.09 $7,476 - $11,983	193 Added 3.91%	5,134 $314,000
Q1 2022 Mar 30, 2023	SELL	$38.74 - $62.09 $512,452 - $821,326	-13,228 Reduced 72.04%	5,134 $314,000
Q1 2022 May 12, 2022	SELL	$38.74 - $62.09 $512,452 - $821,326	-13,228 Reduced 72.04%	5,134 $314,000
Q4 2021 Jun 21, 2023	BUY	$35.2 - $53.42 $472,419 - $716,949	13,421 Added 271.63%	18,362 $961,000
Q4 2021 Mar 30, 2023	SELL	$35.2 - $53.42 $44,352 - $67,309	-1,260 Reduced 6.42%	18,362 $961,000
Q4 2021 Feb 15, 2022	SELL	$35.2 - $53.42 $44,352 - $67,309	-1,260 Reduced 6.42%	18,362 $961,000
Q3 2021 Jun 21, 2023	BUY	$28.72 - $42.49 $421,638 - $623,795	14,681 Added 297.13%	19,622 $731,000
Q3 2021 Mar 30, 2023	BUY	$28.72 - $42.49 $2,728 - $4,036	95 Added 0.49%	19,622 $731,000
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $2,728 - $4,036	95 Added 0.49%	19,622 $732,000
Q2 2021 Jun 21, 2023	BUY	$29.3 - $44.5 $427,369 - $649,077	14,586 Added 295.2%	19,527 $797,000
Q2 2021 Mar 30, 2023	BUY	$29.3 - $44.5 $34,574 - $52,510	1,180 Added 6.43%	19,527 $797,000
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $571,613 - $868,150	19,509 Added 108383.33%	19,527 $797,000
Q1 2021 Jun 26, 2023	BUY	$30.8 - $39.51 $412,904 - $529,671	13,406 Added 271.32%	18,347 $623 Million
Q1 2021 Mar 30, 2023	SELL	$30.8 - $39.51 $22,022 - $28,249	-715 Reduced 3.75%	18,347 $622,000
Q1 2021 May 14, 2021	SELL	$30.8 - $39.51 $586,555 - $752,428	-19,044 Reduced 99.91%	18 $623,000
Q4 2020 Jun 22, 2023	BUY	$23.34 - $32.22 $329,584 - $454,978	14,121 Added 285.79%	19,062 $606,000
Q3 2020 Jun 26, 2023	BUY	$17.61 - $31.86 $248,670 - $449,895	14,121 Added 285.79%	19,062 $489,000
Q3 2020 Mar 30, 2023	BUY	$17.61 - $31.86 $45,962 - $83,154	2,610 Added 15.86%	19,062 $489,000
Q3 2020 Nov 13, 2020	BUY	$17.61 - $31.86 $45,962 - $83,154	2,610 Added 15.86%	19,062 $489,000
Q2 2020 Jun 26, 2023	BUY	$14.35 - $26.64 $165,182 - $306,653	11,511 Added 232.97%	16,452 $422,000
Q1 2020 Jul 12, 2023	BUY	$12.31 - $33.12 $141,700 - $381,244	11,511 Added 232.97%	16,452 $252,000
Q1 2020 Mar 30, 2023	BUY	$12.31 - $33.12 $44,131 - $118,735	3,585 Added 27.86%	16,452 $252,000
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $44,131 - $118,735	3,585 Added 27.86%	16,452 $253,000
Q4 2019 Jul 12, 2023	BUY	$7.26 - $38.49 $57,542 - $305,071	7,926 Added 160.41%	12,867 $441,000
Q4 2019 Mar 30, 2023	SELL	$7.26 - $38.49 $8,341 - $44,225	-1,149 Reduced 8.2%	12,867 $441,000
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $8,341 - $44,225	-1,149 Reduced 8.2%	12,867 $441,000
Q3 2019 Jul 12, 2023	BUY	$7.47 - $14.03 $67,790 - $127,322	9,075 Added 183.67%	14,016 $104,000
Q2 2019 Jul 12, 2023	BUY	$10.65 - $14.29 $96,648 - $129,681	9,075 Added 183.67%	14,016 $181,000
Q1 2019 Jul 13, 2023	BUY	$10.9 - $14.09 $98,917 - $127,866	9,075 Added 183.67%	14,016 $170,000
Q1 2019 Mar 30, 2023	BUY	$10.9 - $14.09 $90,153 - $116,538	8,271 Added 143.97%	14,016 $170,000
Q1 2019 May 16, 2019	BUY	$10.9 - $14.09 $71,831 - $92,853	6,590 Added 88.74%	14,016 $170,000
Q1 2019 May 15, 2019	SELL	$10.9 - $14.09 $71,831 - $92,853	-6,590 Reduced 47.02%	7,426 $704,000
Q4 2018 Jul 13, 2023	BUY	$10.36 - $20.96 $94,017 - $190,212	9,075 Added 183.67%	14,016 $159,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $113,276 - $229,176	10,934 Added 354.77%	14,016 $160,000
Q3 2018 Jul 13, 2023	BUY	$17.77 - $22.9 $161,262 - $207,817	9,075 Added 183.67%	14,016 $304 Million
Q3 2018 Nov 14, 2018	SELL	$17.77 - $22.9 $194,297 - $250,388	-10,934 Reduced 78.01%	3,082 $67,000
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $11,612 - $19,525	766 Added 5.78%	14,016 $0
Q4 2017 Feb 15, 2018	SELL	$14.27 - $16.79 $170,012 - $200,036	-11,914 Reduced 47.35%	13,250 $192,000
Q2 2017 Aug 14, 2017	BUY	N/A	25,164	25,164 $313,000

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

84M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$1.22 Billion
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$798 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$667 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$486 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$385 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account